Abstract: The present invention provides methods for providing a prognosis for lung adenocarcinoma, using a panel of eight molecular markers that are differentially expressed in lung adenocarcinoma.

Abstract: A method and circuit for controlling or starting a U-shape single phase synchronous permanent magnetic motor (U-SPSPM motor) having a rotor and a stator and coupled to a single phase alternating current (AC) power source through a switch, including estimating back electromotive force (back-EMF) of the motor based on an observer model with inputs indicative of the measured signals, and triggering the switch to supply power to the motor based on the estimates of the back-EMF.

Abstract: Semiconductor structure is provided. The semiconductor structure includes a substrate including device regions and an isolation region located adjacent to and between the device regions; a fin on the substrate; gate structures across the fin at the device regions; source/drain doped regions in the fin at two sides of each of the gate structures; a first opening in the fin at the isolation region; and an insulation structure located in the first opening. Two opposite sidewalls of the first opening are respectively in contact with the source/drain doped regions at adjacent device regions. A top surface of the insulation structure is flush with or higher than top surfaces of the source/drain doped regions.

Abstract: A low-power image capture device includes a first image buffer in SRAM coupled to receive images from an image sensor, and a second image buffer receiving images transferred in bursts from the first image buffer, the second image buffer implemented in PASR DRAM, the image buffers together operating as a first-in, first-out, (FIFO) buffer. The device includes an activation detector. The PASR DRAM is powered while receiving bursts of images from the first image buffer, and when the image capture device is in the activated mode; and in ultra-low power PASR mode otherwise. A method includes capturing images into the first image buffer, transferring the images in bursts into a second image buffer in PASR DRAM powered while receiving the images in bursts, the PASR DRAM otherwise in ultra-low power PASR mode; and, upon activating, an image processor receiving images from the second image buffer.

Abstract: Semiconductor structure and method for fabricating a semiconductor structure are provided. A substrate including device regions and an isolation region located adjacent to and between the device regions is provided. A fin on the substrate, gate structures across the fin at the device regions, source/drain doped regions in the fin at two sides of each of the gate structures, and a sacrificial gate across the fin at the isolation region are provided. The sacrificial gate and a portion of the fin near a bottom of the sacrificial gate are removed, thus forming a first opening in the fin. An insulation structure in the first opening is formed. Two sides of the sacrificial gate are in contact with the source/drain doped regions at adjacent device regions. A top surface of the insulation structure is flush with or higher than top surfaces of the source/drain doped regions.

Abstract: A hybrid storage device includes an interface configured to electrically couple the hybrid storage device to an external device, and exchange data with the external device, a plurality of storage channels electrically coupled to the interface and configured to exchange the data with the interface, a plurality of chip select lines, where each of the chip select lines is electrically coupled to one storage channel in the storage channels and configured to exchange the data with the one storage channel, and a plurality of storage medium particles, where each of the storage medium particles is electrically coupled to one chip select line and configured to exchange the data with the one chip select line. The storage medium particles include a non-volatile random-access memory (NVRAM) and a flash memory.

Abstract: The present invention provides the complete genomic sequence of the epidemic mumps virus (MuV) strain MuVIowa/US/06. Further, a reverse genetics system was constructed and used to rescue recombinant viral constructs that are attenuated compared to rMuVIowa/US/06 and JL vaccine viruses. Such constructs include viral constructs lacking the open reading frame (ORF) of the SH gene (rMuV?SH) and/or incapable of expressing the V protein (rMuV?V).

Abstract: A pressing machine comprising a base, wherein a first inner edge side plate and a second outer edge side plate are arranged on the base; a clamping chamber with sealed inner and outer end surfaces is reserved between the outer wall of the first inner edge side plate and the inner wall of the of the second outer edge side plate; the interior of the clamping chamber is used for preparing sandwich panels; the first inner edge side plate comprises a first side plate assembly, a second side plate assembly, a third side plate assembly and a fourth side plate assembly, wherein the four groups of the side plate assemblies are arranged in parallel in pairs; each side plate assembly is formed by assembling a plurality of side plate units along the length direction of the corresponding side plate assembly.

Abstract: A method and circuit for controlling or starting a U-shape single phase synchronous permanent magnetic motor (U-SPSPM motor) having a rotor and a stator and coupled to a single phase alternating current (AC) power source through a switch, including estimating back electromotive force (back-EMF) of the motor based on an observer model with inputs indicative of the measured signals, and triggering the switch to supply power to the motor based on the estimates of the back-EMF.

Abstract: The present disclosure provides compounds, pharmaceutical compositions, and methods for the treatment of cancer and fibrosis. The disclosed pharmaceutical compositions may include one or more pyrazolyl-containing compounds, or a derivative thereof.

Abstract: The present invention provides methods for providing a prognosis for lung adenocarcinoma, using a panel of eight molecular markers that are differentially expressed in lung adenocarcinoma.

Abstract: The present invention provides safe, stable, efficacious, and cost-effective vaccines based on viral expression vectors that include a parainfluenza virus 5 (PIV5) genome including a heterologous nucleotide sequence expressing a heterologous polypeptide.

Abstract: A method and circuit for controlling or starting a U-shape single phase synchronous permanent magnetic motor (U-SPSPM motor) having a rotor and a stator and coupled to a single phase alternating current (AC) power source through a switch, including estimating back electromotive force (back-EMF) of the motor based on an observer model with inputs indicative of the measured signals, and triggering the switch to supply power to the motor based on the estimates of the back-EMF.

Abstract: A pressing machine comprising a base, wherein a first inner edge side plate and a second outer edge side plate are arranged on the base; a clamping chamber with sealed inner and outer end surfaces is reserved between the outer wall of the first inner edge side plate and the inner wall of the of the second outer edge side plate; the interior of the clamping chamber is used for preparing sandwich panels; the first inner edge side plate comprises a first side plate assembly, a second side plate assembly, a third side plate assembly and a fourth side plate assembly, wherein the four groups of the side plate assemblies are arranged in parallel in pairs; each side plate assembly is formed by assembling a plurality of side plate units along the length direction of the corresponding side plate assembly.

Abstract: The present invention provides safe, stable, efficacious, and cost-effective vaccines based on viral expression vectors that include a parainfluenza virus 5 (PIV5) genome including a heterologous nucleotide sequence expressing a heterologous polypeptide.

Abstract: Compositions, methods of use and methods of manufacture are provided for PIV5-based amplifying VLP (AVLP) that can deliver an expressible heterologous nucleotide sequence in target cells without producing progeny, and which demonstrate useful safety and therapeutic efficacy in multiple animal and human health applications, such as vaccination, gene therapy and cancer therapy.

Abstract: A method and circuit for controlling or starting a U-shape single phase synchronous permanent magnetic motor (U-SPSPM motor) having a rotor and a stator and coupled to a single phase alternating current (AC) power source through a switch, including estimating back electromotive force (back-EMF) of the motor based on an observer model with inputs indicative of the measured signals, and triggering the switch to supply power to the motor based on the estimates of the back-EMF.

Abstract: Semiconductor structure and method for fabricating a semiconductor structure are provided. A substrate including device regions and an isolation region located adjacent to and between the device regions is provided. A fin on the substrate, gate structures across the fin at the device regions, source/drain doped regions in the fin at two sides of each of the gate structures, and a sacrificial gate across the fin at the isolation region are provided. The sacrificial gate and a portion of the fin near a bottom of the sacrificial gate are removed, thus forming a first opening in the fin. An insulation structure in the first opening is formed. Two sides of the sacrificial gate are in contact with the source/drain doped regions at adjacent device regions. A top surface of the insulation structure is flush with or higher than top surfaces of the source/drain doped regions.

Abstract: A method and circuit for controlling or starting a U-shape single phase synchronous permanent magnetic motor (U-SPSPM motor) having a rotor and a stator and coupled to a single phase alternating current (AC) power source through a switch, including estimating back electromotive force (back-EMF) of the motor based on an observer model with inputs indicative of the measured signals, and triggering the switch to supply power to the motor based on the estimates of the back-EMF.

Abstract: The present invention includes the Paramyxovirus Parainfluenza Virus 5 (PIV5) as an oncolytic agent for treating various cancers, including, but not limited to breast cancer, lung cancer and melanoma. PIV5 oncolytic agents include both wild type PIV5 and various recombinant PIV5 constructs. Recombinant PIV5 constructs may include PIV5 lacking the conserved C-terminus of the V protein (PIV5V?C), PIV5 with mutations in the N-terminus of the V/P protein (PIV5CPI?), and PIV5 expressing MDA-7/IL-24 (rPIV5-MDA7), rPIV5-V/P-CPI?, rPIV5-CPI+, rPIV5-Rev, rPIV5-RL, rPIV5-P-S157A, rPIV5-P-S308A, rPIV5-L-A1981D, rPIV5-F-S443P, rPIV5-MDA7, rPIV5?SH-CPI?, or rPIV5?SH-Rev. Also included are methods of making and using such oncolytic agents and compositions including such oncolytic agents.